1. Lupus erythematosus cell phenomenon in patients with chronic ulcerative colitis;ALARCON-SEGOVIA, D.; HERSKOVIC, T.; DEARINO, W.H.B.A.R.T.H.O.L.O.M.E.W.; G., L.; CAIN, J.C.; SHURER, R.C.;Gut,1965
2. Preliminary criteria for the classification of systemic lupus erythematosus;COHEN, S.A.; REYNOLDS, W.E.; FRANKLIN, F.C.; KULKA, J.P.; RopEs, M.W.; SHULMAN, L.E.; WALLACE, S.L.;Bulletin of Rheumatic Diseases,1971
3. Sulphasalazine-induced systemic lupus erythematosus in a patient with Sjogren's syndrome;CRISP, A.J.; HOFFBRAND, B.I.;Journal of the Royal Society of Medicine,1980
4. The metabolism of salicylazo-sulphapyridine in ulcerative colitis; 1. The relationship between metabolites and the response to treatment in inpatients;DAS, K.M.; EASTWOOD, M.A.; MCMANUS, J.P.A.; SIRCUS, W.;Gut,1973
5. Sulphasalazine-induced lupus syndrome in ulcerative colitis;GRIFFITHS, I.D.; KANE, S.P.;British Medical Journal,1977